MetaCap

Molecular Partners Statistics

NASDAQ: MOLNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

2.53-0.14 (-5.25%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Molecular Partners by the numbers

Molecular Partners has a market capitalization of $96.8 million based on 38.34M shares outstanding. With trailing EPS of $-1.68, Molecular Partners is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 29.8% below its 50-day average and 38.1% below its 200-day average.

Average daily trading volume is 1.63K shares, or about $4,126 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

MOLN valuation vs. peer median

MOLN compared with the median of 8 peer companies
MetricMOLNPeer medianDifference
Market cap$96.80M$95.83M+1%
Avg. volume1.63K1.05M-100%

Peer median across 8 companies: IPHA, VYGR, OTLK, LENZ, ZURA, CRDL, FATE, ARMP.

Valuation

Price and trading

Previous close
2.67
Open
2.53
Day range
2.53 – 2.53
52-week range
2.52 – 5.36
52-week change
-37.50%
Beta
—

Dividends and events

Annual dividend
None
Next earnings date
Aug 25, 2026

Additional statistics

Market Cap
96.80M
Forward Pe
-19.63
Eps
-1.68
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
5.36
Week52 Low
2.52
Avg Volume
1,634.00
Shares Outstanding
38.34M
Ma50
3.60
Ma200
4.08
Earnings Date
Aug 25, 2026
Pct From52w High
-52.89%
Pct From52w Low
0.20%

Related